Latest multiple sclerosis Stories
ALISO VIEJO, Calif., June 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the presentation of three posters, including preliminary results from the PRISM patient registry, at the Fourth Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Americas Committee for Treatment and Research in Multiple Sclerosis. PRISM Registry The aims of the PRISM registry are to define pseudobulbar affect (PBA) prevalence and its...
On World MS Day, May 30, people from more than 70 countries are joining together to raise awareness and unite in the MS Movement NEW YORK, May 30, 2012 /PRNewswire-USNewswire/ -- Multiple sclerosis is a life altering disease that affects each person in a unique and different way. More than 2.1 million people worldwide live with MS, which is why demonstrating the power and importance of the global MS movement is critical on World MS Day, today -- May 30. (Logo:...
TORONTO, May 23, 2012 /CNW/ - Today Biogen Idec announced that Health Canada has approved a product monograph change for TYSABRI® that will help enable individual benefit risk assessment for patients with multiple sclerosis (MS). The new label identifies anti-JC virus (JCV) antibody status as a risk factor for developing an uncommon, but serious, brain infection known as progressive multifocal leukoencephalopathy (PML). This marks the third risk factor identified to help...
SAN DIEGO, May 18, 2012 /PRNewswire/ -- Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics from around the world to share the latest research in gastrointestinal health topics, for which DDW is the premier...
(Ivanhoe Newswire) – A new study finds that smoked cannabis can provide relief from pain and muscular tightness - otherwise known as spasticity – in people with multiple sclerosis at the risk of adverse cognitive effects. Spasticity causes patients with multiple sclerosis to suffer from muscular tightness that is difficult to control, often uncomfortable and disabling. Spasticity can be relieved by some drugs, but they can have adverse effects and often do not always improve the...
ANN ARBOR, Mich., May 15, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, today reported financial results for the three months ended March 31, 2012 and summarized operational highlights. Operational Highlights Management Team - Strengthened Clinical Development and Regulatory Affairs Functions Recruited former Chief Medical Officer of Clinical...
Connie K. Ho for RedOrbit.com The benefits and drawbacks of cannabis have long been discussed in the medical community. And now, a new study looks at how cannabis can affect the pain of multiple sclerosis (MS) patients. Many patients of MS report to have spasticity, which is a condition that makes their muscles tight and difficult to control. There are some drugs that are available, but many of these treatments tend to not show improvement in patients’ conditions. The report, recently...
GLEN ALLEN, Va., May 8, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) through its wholly owned subsidiary, Rock Creek Pharmaceuticals Inc., announces that it has received important new research findings from its research partner, The Roskamp Institute of Sarasota, Florida. The Institute has completed a successful animal study of nutritional supplementation with Rock Creek's specially formulated anatabine (patent pending), in an animal model of multiple sclerosis. The...
EAST HANOVER, N.J., May 8, 2012 /PRNewswire/ -- Phil Keoghan, host of "The Amazing Race," and the women cyclists of the professional "NOW and Novartis for MS" team are joining with Novartis Pharmaceuticals Corporation for a second year in a row to raise awareness of MS. The campaign, "Together in MS," will support the MS community and show that MS does not have to define the more than 400,000 people in the U.S. living with the disease. To view the multimedia assets associated...
Researchers studying multiple sclerosis (MS) have long been looking for the specific molecules in the body that cause lesions in myelin, the fatty, insulating cells that sheathe the nerves. Nearly a decade ago, a group at Mayo Clinic found a new enzyme, called Kallikrein 6, that is present in abundance in MS lesions and blood samples and is associated with inflammation and demyelination in other neurodegenerative diseases. In a study published this month in Brain Pathology, the same group...
